Customize your JAMA Network experience by selecting one or more topics from the list below.
Miech RA, Patrick ME, O’Malley PM, Johnston LD, Bachman JG. Trends in Reported Marijuana Vaping Among US Adolescents, 2017-2019. JAMA. 2020;323(5):475–476. doi:10.1001/jama.2019.20185
Adolescents who vape use portable devices with a heating element to aerosolize a liquid that they inhale. Nicotine use is most common, but tetrahydrocannabinol (the principal psychoactive constituent of marijuana) can also be vaped. Marijuana vaping produces significantly greater physiological and psychological effects compared with traditional smoking methods at the same tetrahydrocannabinol levels,1 raising concerns about potential health effects. This study reports the prevalence of marijuana vaping for 2019 among US adolescents and the prevalence increases between 2017, 2018, and 2019.
Monitoring the Future2 annually surveys nationally representative samples of 8th, 10th, and 12th graders between February and June. Each year schools from 368 randomly selected geographic units throughout the contiguous United States are sampled, with a school successfully recruited from 90% of these units for 2017, 2018, and 2019. Student participation rates were 88% among 8th graders, 86% among 10th graders, and 80% among 12th graders.
Analyses were based on the question “On how many days (if any) have you vaped marijuana?” with the time periods of “during the last 30 days,” “during the last 12 months,” and “in your lifetime.” In 2019, the word “days” in the stem question replaced the word “occasions,” which was used in 2017 and 2018. In 2019 “near-daily” marijuana vaping was measured for the first time and indicated use on “20+ days” during the past 30 days. A randomly selected two-thirds sample received the marijuana vaping questions in 2019, and a randomly selected one-third sample received the questions in 2017 and 2018.
Analyses used version 15.1 of Stata MP software (StataCorp) with svy: commands to take into account the weights, clustering, and strata of the complex sampling design.3 Prevalence increases across adjacent years, as well as differences in magnitude of these increases during the study period, were tested for statistical significance with Wald tests using Stata’s lincom command. Statistical significance was defined as P < .05 (2-sided).
The University of Michigan institutional review board approved the study. Informed consent (active or passive per school policy) was obtained from the parents for students who were younger than 18 years and from the students who were aged 18 years or older.
The number of students randomly selected to receive the marijuana vaping questions was 14 560 of 43 703 in 2017, 14 857 of 44 482 in 2018, and 28 346 of 42 531 in 2019.
In 2019, past 30-day prevalence of marijuana vaping was reported by 3.9% (95% CI, 3.3%-4.7%) of 8th graders, 12.6% (95% CI, 11.1%-14.3%) of 10th graders, and 14.0% (95% CI, 12.6%-15.5%) of 12th graders (Table).
Reported past 30-day prevalence levels significantly increased from 2018 to 2019. The absolute increases were 1.3% (95% CI, 0.4%-2.2%; P = .006) in 8th graders, 5.6% (95% CI, 3.7%-7.5%; P < .001) in 10th graders, and 6.5% (95% CI, 4.7%-8.4%; P < .001) in 12th graders. Among 12th graders, this increase was significantly larger than the increase from 2017 to 2018 by an absolute difference of 4.0% (ie, 6.5% − 2.5% [95% CI, 1.3%-6.8%]; P = .004). Among 10th graders, the increase was by 2.9% (ie, 5.6% − 2.7% [95% CI, 0.1%-5.7%]; P = .04).
Results were similar for use during the past 12 months and lifetime use. Prevalence increases in every year were statistically significant for all grades. For all reporting intervals, the prevalence increases among 12th graders were larger from 2018 to 2019 than from 2017 to 2018 (Table).
In 2019, near daily marijuana vaping was reported by 0.8% (95% CI, 0.6%-1.2%) of 8th graders, 3.0% (95% CI, 2.3%-4.0%) of 10th graders, and 3.5% (95% CI, 2.9%-4.3%) of 12th graders (Table).
Reported adolescent marijuana vaping increased from 2018 to 2019. The absolute increases from 2018 to 2019 among 12th graders for past 30-day use are the second largest, single-year increases ever tracked by Monitoring the Future for any substance in its 45-year history (increased nicotine vaping from 2017 to 2018 ranks first).2
Study limitations include potential for reporting error and the absence of high-school dropouts.
As the number of adolescents who vape marijuana increases, so too does the scope and effect of any associated health consequences, which may include lung injury when using black market formulations.4 The rapid rise of marijuana vaping indicates the need for new prevention and intervention efforts aimed specifically at adolescents.
Accepted for Publication: November 19, 2019.
Corresponding Author: Richard A. Miech, PhD, Institute for Social Research, University of Michigan, 426 Thompson St, Ann Arbor, MI 48104 (email@example.com).
Published Online: December 17, 2019. doi:10.1001/jama.2019.20185
Author Contributions: Dr Miech had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Miech, Patrick, O’Malley, Bachman.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Miech, Bachman.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Miech, Johnston, Bachman.
Obtained funding: Miech, Patrick, O’Malley, Bachman.
Administrative, technical, or material support: All authors.
Supervision: Miech, Bachman.
Conflict of Interest Disclosures: None reported.
Funding/Support: This research was supported by award R01DA001411 from the National Institute on Drug Abuse.
Role of the Funder/Sponsor: The National Institute on Drug Abuse had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Create a personal account or sign in to: